PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 116 filers reported holding PROVENTION BIO INC in Q4 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $27,552,518 | +233.6% | 1,143,258 | +46.3% | 0.01% | +500.0% |
| Q4 2022 | $8,259,514 | +344.3% | 781,411 | +89.1% | 0.00% | – |
| Q3 2022 | $1,859,000 | +85.9% | 413,240 | +65.2% | 0.00% | – |
| Q2 2022 | $1,000,000 | -54.8% | 250,198 | -17.3% | 0.00% | – |
| Q1 2022 | $2,213,000 | -26.3% | 302,398 | -43.4% | 0.00% | – |
| Q4 2021 | $3,004,000 | +1.6% | 534,630 | +15.7% | 0.00% | – |
| Q3 2021 | $2,957,000 | -36.9% | 462,076 | -16.9% | 0.00% | – |
| Q2 2021 | $4,686,000 | -8.7% | 555,974 | +13.6% | 0.00% | – |
| Q1 2021 | $5,135,000 | -43.0% | 489,314 | -8.0% | 0.00% | -100.0% |
| Q4 2020 | $9,008,000 | +88.2% | 531,854 | +42.6% | 0.00% | – |
| Q3 2020 | $4,786,000 | -33.4% | 372,946 | -26.8% | 0.00% | -100.0% |
| Q2 2020 | $7,186,000 | +75.8% | 509,298 | +14.6% | 0.00% | 0.0% |
| Q1 2020 | $4,088,000 | -13.6% | 444,401 | +40.0% | 0.00% | 0.0% |
| Q4 2019 | $4,730,000 | +557.9% | 317,452 | +200.9% | 0.00% | – |
| Q3 2019 | $719,000 | -20.0% | 105,486 | +41.9% | 0.00% | – |
| Q2 2019 | $899,000 | – | 74,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 14,879,023 | $157,271,273 | 9.67% |
| MPM BioImpact LLC | 898,483 | $9,496,965 | 2.46% |
| VR Adviser, LLC | 1,118,653 | $11,824,162 | 1.99% |
| Ghost Tree Capital, LLC | 400,000 | $4,228,000 | 1.80% |
| EAM Investors, LLC | 276,250 | $2,919,963 | 0.60% |
| EAM Global Investors LLC | 209,856 | $2,218,178 | 0.57% |
| 683 Capital Management, LLC | 550,000 | $5,813,500 | 0.49% |
| Palo Alto Investors LP | 390,800 | $4,130,756 | 0.35% |
| CABOT WEALTH MANAGEMENT INC | 184,271 | $1,948 | 0.33% |
| ADVISORY RESEARCH INC | 288,707 | $3,051,633 | 0.29% |